Published on Bioscience Technology (https://biosciencetechnology.com)

Home > Complement 3b Deposition on Rituximab Opsonized

Complement 3b Deposition on Rituximab Opsonized

Submitted by mschooler on
EMD Millipore

The ImageStream® imaging flow cytometry platform was used to study the mechanism of action of Rituximab (RTX). RTX is a therapeutic monoclonal antibody directed against CD20 for the treatment of Non-Hodgkin’s lymphoma.

Source URL (retrieved on 09/15/2015 - 6:08am): https://biosciencetechnology.com/white-papers/2015/07/complement-3b-deposition-rituximab-opsonized